angiotensin ii has been researched along with Hibernation, Myocardial in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hintze, TH; Huang, H; Kaley, G; Kaminski, PM; Kinugawa, S; Ochoa, M; Post, H; Recchia, FA; Wolin, MS; Xu, X; Zhang, X | 1 |
Gelpi, RJ; Morales, C; Rodríguez, M; Scapín, O | 1 |
Hoshi, K; Ichihara, K; Kosugi, T; Nakai, T; Satoh, K | 1 |
Ferrier, GR; Howlett, SE; Louch, WE | 1 |
4 other study(ies) available for angiotensin ii and Hibernation, Myocardial
Article | Year |
---|---|
Coronary microvascular endothelial stunning after acute pressure overload in the conscious dog is caused by oxidant processes: the role of angiotensin II type 1 receptor and NAD(P)H oxidase.
Topics: Acetophenones; Angiotensin II; Animals; Ascorbic Acid; Bradycardia; Bradykinin; Coronary Circulation; Cyclic N-Oxides; Dogs; Hypotension; Ligation; Losartan; Myocardial Stunning; Nitric Oxide; Oxidative Stress; Pressure; Reflex; Spin Labels; Superoxides; Veratrine | 2003 |
Comparison of the effects of ACE inhibition with those of angiotensin II receptor antagonism on systolic and diastolic myocardial stunning in isolated rabbit heart.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Diastole; Enalaprilat; In Vitro Techniques; Losartan; Myocardial Contraction; Myocardial Stunning; Rabbits; Systole | 1998 |
Participation of angiotensin II and bradykinin in contractile function in dog stunned myocardium.
Topics: Adenosine Triphosphate; Anesthesia; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Coronary Circulation; Dogs; Dose-Response Relationship, Drug; Enalapril; Female; Heart Rate; In Vitro Techniques; Ligation; Male; Myocardial Contraction; Myocardial Reperfusion; Myocardial Stunning; Telmisartan; Time Factors; Ventricular Pressure | 1999 |
Losartan improves recovery of contraction and inhibits transient inward current in a cellular model of cardiac ischemia and reperfusion.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Guinea Pigs; Heart Ventricles; Losartan; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Stunning; Patch-Clamp Techniques; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2 | 2000 |